Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Apyx Medical (APYX) Gross Margin (2016 - 2025)

Apyx Medical's Gross Margin history spans 15 years, with the latest figure at 62.61% for Q4 2025.

  • For Q4 2025, Gross Margin fell 42.0% year-over-year to 62.61%; the TTM value through Dec 2025 reached 62.53%, up 149.0%, while the annual FY2025 figure was 62.53%, 149.0% up from the prior year.
  • Gross Margin reached 62.61% in Q4 2025 per APYX's latest filing, down from 64.43% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 72.22% in Q4 2021 to a low of 58.07% in Q1 2024.
  • Average Gross Margin over 5 years is 64.39%, with a median of 63.8% recorded in 2022.
  • Peak YoY movement for Gross Margin: surged 1838bps in 2021, then crashed -688bps in 2022.
  • A 5-year view of Gross Margin shows it stood at 72.22% in 2021, then dropped by -10bps to 65.35% in 2022, then decreased by -7bps to 60.9% in 2023, then rose by 3bps to 63.03% in 2024, then decreased by -1bps to 62.61% in 2025.
  • Per Business Quant, the three most recent readings for APYX's Gross Margin are 62.61% (Q4 2025), 64.43% (Q3 2025), and 62.28% (Q2 2025).